Pharma stocks have lost favour amongst investors owing to the USFDA regulatory headwinds. However,...
GST
The Government’s sudden move to levy tax on the capital gains earned by foreign...
A specialty chemical stock described by Sanjoy Bhattacharyya as the “solitary beacon of hope”...
Saurabh Mukherjea, the whiz-kid from Ambit, is proving to be a tough nut to...
Dolly Khanna appears to have overcome her aversion to Pharma stocks. This time, instead...
A mid-cap Pharma stock strongly recommended by Sanjoy Bhattacharyya & Saurabh Mukherjea is facing...
Rahul Arora of Nirmal Bang has put the spotlight on a top-quality stock backed...
Leading experts have sent the clarion call that there is a massive opportunity brewing...
Amar Amabani of IIFL has recommended four top-quality mid-cap stocks with the potential of...
If you are feeling jittery about India’s growth prospects and NAMO’s ability to deliver...
